Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a platform update without changing the study details or other content on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.5.3 was added, replacing Revision: v3.5.2. This indicates a new version of the page was deployed.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study page now displays 'Results Submitted' where it previously showed 'No Results Posted', indicating that results are available or under review for this record.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page. No study data, eligibility criteria, or on-page guidance were changed.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.